<--- Back to Details
First PageDocument Content
Coagulation / Tissue factor / Thrombin / Partial thromboplastin time / Factor X / Hemostasis / Fibrin / Thrombus / Von Willebrand disease / Coagulation system / Blood / Anatomy
Date: 2009-07-22 05:30:33
Coagulation
Tissue factor
Thrombin
Partial thromboplastin time
Factor X
Hemostasis
Fibrin
Thrombus
Von Willebrand disease
Coagulation system
Blood
Anatomy

Coagulation simplified ... tissue factor phospholipid Ca++ Ca++ Ca++

Add to Reading List

Source URL: www.instandev.de

Download Document from Source Website

File Size: 2,13 MB

Share Document on Facebook

Similar Documents

Veterinärmedizinisches Labor Universität Zürich Winterthurerstrasse 260 CH-8057 Zürich Telefon +Telefax +

Veterinärmedizinisches Labor Universität Zürich Winterthurerstrasse 260 CH-8057 Zürich Telefon +Telefax +

DocID: 1powD - View Document

Routine Coagulation Reagents Activated Partial Thromboplastin Time (aPTT) Antithrombin III (ATIII) Prothrombin Time (PT) Thrombin Time (TT) Fibrinogen

Routine Coagulation Reagents Activated Partial Thromboplastin Time (aPTT) Antithrombin III (ATIII) Prothrombin Time (PT) Thrombin Time (TT) Fibrinogen

DocID: 1aOgJ - View Document

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of M118, a Novel Rationally Engineered Low Molecular Weight Heparin Given as a Subcutaneous Injection in a Rising Dose Cohort Regimen in Healthy Subjects S. Bou

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of M118, a Novel Rationally Engineered Low Molecular Weight Heparin Given as a Subcutaneous Injection in a Rising Dose Cohort Regimen in Healthy Subjects S. Bou

DocID: 19tt1 - View Document

Efficacy of M118, a Rationally-Engineered Low-Molecular-Weight Heparin, in a Canine Model of Arterial Thrombosis Ian D Fier1, Mark A Nedelman1, J Luis Guerrero2, Ganesh Venkataraman1, and Yi Wei Qi1 Momenta Pharmaceutica

Efficacy of M118, a Rationally-Engineered Low-Molecular-Weight Heparin, in a Canine Model of Arterial Thrombosis Ian D Fier1, Mark A Nedelman1, J Luis Guerrero2, Ganesh Venkataraman1, and Yi Wei Qi1 Momenta Pharmaceutica

DocID: 19s56 - View Document

Figure 2:  Mean ACT with Increasing Dose of M118

Figure 2: Mean ACT with Increasing Dose of M118

DocID: 19obY - View Document